9996.T
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
The company maintains a strong capital structure with a low debt-to-equity ratio of 0.03, indicating minimal reliance on debt financing. Its liquidity position is characterized by a current ratio of 1.92, suggesting the company has sufficient short-term assets to cover its short-term liabilities. The company's free cash flow of 518,715,000 JPY indicates positive cash generation after capital expenditures, supporting operational flexibility.
Profitability metrics show a return on equity of 5.01% and a return on assets of 3.69%, which are below the industry median for the Food Retail & Distribution sector. This suggests the company is underperforming in terms of capital efficiency and asset utilization compared to its peers.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes.
The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The operating cash flow is negative at -230,137,000 JPY, indicating potential challenges in converting operations into cash.
Risk factors include a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure remains stable, with no near-term pressure for equity issuance.
Recent events include the latest actual EPS of 157.69 JPY and actual revenue of 49,137,190,000 JPY, aligning with analyst estimates. No significant new filings or transcripts have been reported that would indicate a material change in the company's financial position.
- The company has a low debt-to-equity ratio, indicating a conservative capital structure.
- Return on equity and return on assets are below industry medians, suggesting underperformance in capital efficiency.
- The company's revenue is concentrated in a single segment, increasing exposure to regional and regulatory risks.
- Free cash flow is positive, supporting operational flexibility and potential for reinvestment.
- No immediate liquidity or dilution risks are present, with a stable capital structure.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 9996.T Market data — financials · 2026-05-27
- Satoh&Co Ltd Market data — analyst estimates · 2026-05-27